• Western blot analysis of various lysates using CFAP44 Rabbit polyclonal antibody (STJ116750) at 1:3000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 90s.

Anti-CFAP44 antibody (180-370) (STJ116750)

SKU:
STJ116750

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CFAP44 (180-370) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CFAP44
Gene ID: 55779
Uniprot ID: CFA44_HUMAN
Immunogen Region: 180-370
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 180-370 of human CFAP44 (NP_001157968.1).
Immunogen Sequence: SSSGEGIGVIGVHPHKTYFT VAEKGSFPDIIIYEYPSLRP YRVLRDGTEKGYAYVDFNYS GNLLASVGSNPDYTLTIWNW KEEQPILRTKAFSQEVFKVT FNPDKEEQLTTSGSGHIKFW EMAFTFTGLKLQGSLGRFGK TITTDIEGYMELPDGKVLSG SEWGNMLLWEGGLIKVELCR GTSKSCHNGPI
Tissue Specificity Testis-specific.
Function Flagellar protein involved in sperm flagellum axoneme organization and function.
Protein Name Cilia- And Flagella-Associated Protein 44
Wd Repeat-Containing Protein 52
Cellular Localisation Cell Projection
Cilium
Flagellum
Cytoplasm
Cytoskeleton
Flagellum Axoneme
Alternative Antibody Names Anti-Cilia- And Flagella-Associated Protein 44 antibody
Anti-Wd Repeat-Containing Protein 52 antibody
Anti-CFAP44 antibody
Anti-WDR52 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance